Anglia Ruskin Research Online (ARRO)
Browse

Biostimulants in aesthetic medicine: a systematic review and meta-analysis of efficacy, safety, and patient satisfaction

journal contribution
posted on 2025-08-05, 15:40 authored by Lee Smith, Masoud Rahmati, Damiano Pizzol, Guillermo Lopez-Sanchez, Laurent Boyer, Guilluame Fond, Bach Xuan Tran, Julia Gawronska, Dong Keon Yon, Roshan Ravindran
<p dir="ltr">Biostimulants, including calcium hydroxyapatite (CaHA), poly-L-lactic acid (PLLA), and polycaprolactone (PCL), have become popular in aesthetic medicine as they lead to long-term tissue rejuvenation. However, their efficacy (e.g. dermal, volume, and anatomic outcomes), satisfaction and safety remain unclear. This systematic review and meta-analysis collates and appraises the available data on biostimulants, examining their efficacy, adverse events and patient satisfaction. A comprehensive search was conducted in PubMed/Medline (National Library of Medicine, Bethesda, MD), Scopus (Elsevier, Amsterdam, the Netherlands), Embase (Elsevier), and Web of Science (Clarivate, Philadelpha, PA, USA), up to January 14<sup>th</sup>, 2025. Studies were included that assessed the effects of biostimulants on efficacy, adverse events and patient satisfaction in observational studies. Meta-analyses using random-effects models were performed on individual proportions and applied to seven outcomes (satisfaction, bruising, ecchymosis, edema, erythema, nodules development, pain). A total of 197 articles were screened, and 25 studies were included in the systematic review. The results of meta-analyses indicate that the pooled satisfaction rate of biostimulants was estimated at 91% (95% CI: 67-98, <i>I</i><sup><em>2</em></sup>= 87.3%); bruising 27% (95% CI: 12-50, <i>I</i><sup><em>2</em></sup>= 96%), ecchymosis 22%; (95% CI: 11-40, <i>I</i><sup><em>2</em></sup>= 95.5%), edema 5%; (95% CI: 1-18, <i>I</i><sup><em>2</em></sup>= 93.6%), erythema 16% (95% CI: 4-47, <i>I</i><sup><em>2</em></sup>= 94.3%), nodules development 5% (95% CI: 2-10, <i>I</i><sup><em>2</em></sup>= 85.5%), pain 92% (95% CI: 63-99, <i>I</i><sup><em>2</em></sup>= 87.7%,). Among studies not included in the meta-analysis all parameters studied showed significant improvements in terms of dermal, volume, anatomic and satisfaction outcomes. Biostimulants demonstrate clinical promise and a favourable tolerability profile in aesthetic medicine, despite the common occurrence of minor adverse events, most notably pain</p>

History

Item sub-type

Article

Refereed

  • Yes

Publication title

Aesthetic Surgery Journal

ISSN

1090-820X

Publisher

Oxford University Press

File version

  • Accepted version

Affiliated with

  • School of Psychology and Sport Science Outputs

Usage metrics

    ARU Outputs

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC